MediPharm Labs Corp. (LABS) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Medipharm Labs Corp..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.181 Thank you for standing by and welcome to the MetaPharm Labs conference call to discuss 00:00:05.181 -- 00:00:09.589 its 2025 full year and fourth quarter results. 00:00:09.589 -- 00:00:14.598 Our speaker on today's call is Greg Hunter, Chief Financial Officer and Interim 00:00:14.598 -- 00:00:17.303 Chief Executive Officer. 00:00:17.303 -- 00:00:23.555 As a reminder, all participants are in listen-only mode and the conference is being recorded. 00:00:23.555 -- 00:00:27.920 After management's presentation, we will take questions from the analyst community on 00:00:27.920 -- 00:00:34.125 the telephone and then take written questions through the Q&A feature on the webcast. 00:00:34.647 -- 00:00:38.411 The information during this call should be considered together with the more detailed 00:00:38.411 -- 00:00:43.597 information disclosure, financial data, and statements available on the company's website 00:00:43.597 -- 00:00:48.240 and on its Cedar Plus profile at cedarplus.ca. 00:00:49.684 -- 00:00:55.010 As set out on the webcast slide, I would like to note the remarks During this 00:00:55.010 -- 00:01:00.098 earnings call may contain forward-looking information and forward-looking statements 00:01:00.098 -- 00:01:03.883 within the meaning of applicable securities laws. 00:01:03.883 -- 00:01:08.991 This includes, without limitation, statements about MetaPharm Labs and its current 00:01:08.991 -- 00:01:14.540 and future plans, expectations, intentions, financial results, 00:01:14.540 -- 00:01:20.189 operations, levels of activity, performance, goals or achievements, 00:01:20.189 -- 00:01:27.088 and other future events, trends, probability, business growth, or developments. 00:01:27.111 -- 00:01:32.358 All statements other than stateme...